Groups | Drug concentration (%, w/w) | Body weight gain (g) | Food intake (g/kg/day) | Drug intake (g/kg/day) | |
---|---|---|---|---|---|
D 1 → D 5 | D 5 → D 10 | ||||
Normal mice | Â | Â | Â | Â | Â |
Control ND | - | 7.41 ± 0.29 | 4.46 ± 0.22 | 156.4 | - |
SAqFSC-P/ND | 1 | 7.52 ± 0.07 | 3.41 ± 0.18a | 142.2 | 1.42 |
 | 9 | 7.19 ± 0.16 | 3.53 ± 0.27a | 157.5 | 14.18 |
PAqFSC-P/ND | 1 | 7.42 ± 0.17 | 3.99 ± 0.36 | 143.7 | 1.44 |
 | 9 | 7.49 ± 0.35 | 4.54 ± 0.26 | 151.4 | 13.63 |
Bicyclol/ND | 0.025 | 7.41 ± 0.20 | 3.70 ± 0.26a | 158.3 | 0.04 |
Hypercholesterolemic mice | Â | Â | Â | Â | Â |
Control ND | - | 10.42 ± 0.25 | 3.04 ± 0.14 | 162.7 | - |
Control HCBD | - | 9.76 ± 0.16a | 2.81 ± 0.12 | 151.0 | - |
SAqFSC-P/HCBD | 1 | 9.71 ± 0.29 | 3.02 ± 0.10 | 151.4 | 1.51 |
 | 3 | 9.36 ± 0.20 | 2.98 ± 0.19 | 150.0 | 4.50 |
PAqFSC-P/HCBD | 1 | 10.02 ± 0.28 | 2.78 ± 0.11 | 150.5 | 1.51 |
 | 3 | 9.66 ± 0.15 | 3.11 ± 0.16 | 157.5 | 4.72 |
Bicyclol/HCBD | 0.025 | 10.36 ± 0.23 | 2.72 ± 0.13 | 152.5 | 0.04 |